SUVARI TRICIA BORGA

CIK 00012384082 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001238408

Recent Transactions

50 trades

Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−40,000→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−13,814→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−26,454→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−28,628→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−40,000→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−38,739→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−43,077→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−42,400→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−9,060→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−15,460→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−100,000→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−38,500→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−3,125→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-09-01−2,763→ 13,814 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01$68.15/sh−1,881→ 43,077 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01+2,763→ 42,750 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01+2,208→ 44,958 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-09-01−2,208→ 15,460 total
Award
Global Blood Therapeutics, Inc.
Common Stock
2022-08-31$25.37/sh+385→ 39,987 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-08-01−3,125→ 3,125 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-08-01$32.40/sh−2,126→ 39,602 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-08-01−3,020→ 9,060 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-08-01+6,145→ 41,728 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to buy)
2022-03-01+28,628→ 28,628 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-03-01$29.87/sh−956→ 35,653 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01+17,668→ 17,668 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01+17,668→ 17,668 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01−2,763→ 16,577 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-03-01+2,763→ 36,609 total
Award
Global Blood Therapeutics, Inc.
Common Stock
2022-02-28$25.37/sh+453→ 33,846 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-02-01$29.33/sh−3,470→ 33,393 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-02-01+9,395→ 36,863 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-02-01−3,020→ 12,080 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-02-01−3,125→ 6,250 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-02-01−3,250→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2021-09-01+2,762→ 28,515 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-09-01−2,762→ 19,340 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2021-09-01$29.85/sh−1,047→ 27,468 total
Award
Global Blood Therapeutics, Inc.
Common Stock
2021-08-31$24.39/sh+43→ 25,753 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-08-01−3,250→ 3,250 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-08-01−3,020→ 15,100 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-08-01−3,125→ 9,375 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2021-08-01+9,395→ 28,960 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2021-08-01+9,395→ 28,960 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-08-01−3,125→ 9,375 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-08-01−3,250→ 3,250 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2021-08-01$27.33/sh−3,250→ 25,710 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-08-01−3,020→ 15,100 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2021-08-01$27.33/sh−3,250→ 25,710 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-03-01+22,102→ 22,102 total

Companies

Recent Filings

Address

3172 PORTER DRIVE

PALO ALTO, CA, 94304

View on SEC.gov